| |
|
|
|
Antares Pharma Inc.  
|
|
3.07 0.05 (0.02%) |
01-15 16:00 |
|
Open: |
3.03 |
Pre close: |
3.02 |
Target:
|
3.84 
|
|
High: |
3.09 |
Low: |
2.96 |
Resistance:
|
3.29
3.84
|
|
Volume: |
677,635 |
Market Cap: |
484M |
Support:
|
2.82
2.53
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
3.09
|
MACD |
MACD(12,26):
|
-0.01  |
|
MA(20): |
2.88 |
Signal(12,26,9): |
-0.06 |
|
MA(100): |
3.30 |
Stochastic Oscillator |
%K(14,3):
|
80.10 |
|
MA(250): |
2.82 |
%D(3): |
84.08 |
|
Average Volume(K) |
3-Month: |
116103
|
52-Week |
High:
|
3.93 |
|
10-Days: |
82665 |
Low: |
1.85 |
|
RSI |
RSI(14):
|
52.49 |
Change(%): |
37.7 |
|
Financials, Statistics and Valuation |
|
EPS |
0.000 |
Return on Equity (ttm) |
-54.2 |
Shares Out. (M) |
157.54 |
|
EPS Est. Current Year |
-0.100 |
Return on Assets (ttm) |
-21.4 |
Shares Float (M) |
141.82 |
|
EPS Est. Next Year |
0.010 |
PEG Ratio |
-0.40 |
% Held by Insiders |
10.00 |
|
EPS Est. Next Quarter |
-0.030 |
Qtrly Rev. Growth |
18.7 |
% Held by Institutions |
52.60 |
|
Forward EPS |
0.050 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
20.230 |
EBITDA (p.s.) |
0.000 |
P/E |
0.00 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.15 |
|
Profit Margin |
-37.60 |
Operating Cash Flow
(M) |
-17.77 |
P/S |
1307156096.00 |
|
Operating Margin |
-25.37 |
Levered Free Cash Flow
(M) |
-4.99 |
P/CF |
-27.22 |
|
|
|
|
|
|
